English
Early Access Program
Our mission is to improve the quality of life of patients by ensuring they have access to the medication they need through our network of existing partners.
Until local regulatory approval is obtained from the relevant local health authorities, these medicines may remain unavailable in the country in which the patient is based, and accordingly patient access may be delayed.
In compliance with local laws and regulations and in collaboration with physicians, institutions, relevant authorities and our business partners, we use our best endeavors to meet requests for such medications through our Early Access Programs.
Fortunately, many health authorities across the MENA Region allow expert physicians to make formal requests on behalf of their patients
through their institutions and health authorities, and in collaboration with pharmaceutical companies, to obtain these essential unregistered medications.
For more information about our Early Access Programs
Please send your inquiry to info@myamgroup.com